AlphaFold predicted structure
CD28 · P10747

Mean pLDDT
81.3/ 100
Confident
220 residues
Confidence breakdown
- Very high(≥ 90)51%
- Confident(70–90)18%
- Low(50–70)30%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
CD28 molecule
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
COVID-19 research
UnknownPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalHIV infectious disease
asthma
immunodeficiency 123 with HPV-related verrucosis
cancer
inflammatory bowel disease
autoimmune disease
hypothyroidism
psoriasis
urolithiasis
alcohol drinking
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
T-cell-specific surface glycoprotein CD28
Receptor that plays a role in T-cell activation, proliferation, survival and the maintenance of immune homeostasis (PubMed:1650475, PubMed:7568038). Functions not only as an amplifier of TCR signals but delivers unique signals that control intracellular biochemical events that alter the gene expression program of T-cells (PubMed:24665965). Stimulation upon engagement of its cognate ligands CD80 or CD86 increases proliferation and expression of various cytokines in particular IL2 production in both CD4(+) and CD8(+) T-cell subsets (PubMed:12196291, PubMed:1650475, PubMed:35397202). Mechanistically, ligation induces recruitment of protein kinase C-theta/PRKCQ and GRB2 leading to NF-kappa-B activation via both PI3K/Akt-dependent and -independent pathways (PubMed:21964608, PubMed:24665965, PubMed:7568038). In conjunction with TCR/CD3 ligation and CD40L costimulation, enhances the production of IL4 and IL10 in T-cells (PubMed:8617933)
CD28 · P10747

Mean pLDDT
81.3/ 100
Confident
220 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0